Found: 23
Select item for more details and to access through your institution.
Oxaliplatin induces prostaglandin E2 release in vascular endothelial cells.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
MSI2-TGF-β/TGF-β R1/SMAD3 positive feedback regulation in glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase I study of BGT226, a pan-PI3K and mTOR inhibitor, in Japanese patients with advanced solid cancers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cancer immunotherapy: the art of targeting the tumor immune microenvironment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The effects of lapatinib on cardiac repolarization: results from a placebo controlled, single sequence, crossover study in patients with advanced solid tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody–drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2019, v. 84, n. 2, p. 327, doi. 10.1007/s00280-019-03879-2
- By:
- Publication type:
- Article
The role of apoptosis defects in malignant mesothelioma pathogenesis with an impact on prognosis and treatment.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Moxetumomab pasudotox-tdfk for relapsed/refractory hairy cell leukemia: a review of clinical considerations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
MicroRNA-552 deficiency mediates 5-fluorouracil resistance by targeting SMAD2 signaling in DNA-mismatch-repair-deficient colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CNS penetration of the CDK4/6 inhibitor ribociclib in non-tumor bearing mice and mice bearing pediatric brain tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Priming with GM-CSF instead of G-CSF enhances CAG-induced apoptosis of acute monocytic leukemia cells in vitro.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Postoperative chemotherapy as adjuvant treatment for endometrioid adenocarcinoma: early stage vs late stage.
- Published in:
- 2019
- By:
- Publication type:
- journal article
SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Exposure time versus cytotoxicity for anticancer agents.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neoadjuvant chemotherapy in patients with advanced endometrial cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine.
- Published in:
- 2019
- By:
- Publication type:
- journal article